Concepedia

Sandhya Mandlekar

SM

Statistics

Publications

50

Citations

3.3K

H-Index

28

Active since

1998

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (India)

Biocon (India)

Syngene International (India)

Bristol-Myers Squibb (Germany)

Sandhya Mandlekar is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, pharmacy, and medicine.

Publications per year

1998–2025

50

Publications

50

Single-Agent Divarasib (GDC-6036) in Solid Tumors with a <i>KRAS</i> G12C Mutation

Adrian G. Sacher, Patricia LoRusso, Manish R. Patel et al. · New England Journal of Medicine · 2023 · 294 citations · Full text

, , +16

Role of a Mitogen-activated Protein Kinase Pathway in the Induction of Phase II Detoxifying Enzymes by Chemicals

Rong Yu, Sandhya Mandlekar, Michael J. Weber et al. · Journal of Biological Chemistry · 1999 · 280 citations · Full text

, , +16

Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity.

Rong Yu, Sandhya Mandlekar, Kevin J. Harvey et al. · PubMed · 1998 · 256 citations

, , +17

Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.

Sandhya Mandlekar, Rong Yu, Tse‐Hua Tan et al. · PubMed · 2000 · 199 citations

, , +17

p38 Mitogen-activated Protein Kinase Negatively Regulates the Induction of Phase II Drug-metabolizing Enzymes That Detoxify Carcinogens

Rong Yu, Sandhya Mandlekar, William E. Fahl et al. · Journal of Biological Chemistry · 2000 · 195 citations · Full text

, , +16

1–5 of 50